5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | NEUTRAL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 7.69▼ | 7.71▼ | 7.70▼ | 7.45▲ | 7.67▼ |
MA10 | 7.70▼ | 7.72▼ | 7.67▼ | 7.55▲ | 7.79▼ |
MA20 | 7.71▼ | 7.67▼ | 7.63▲ | 7.81▼ | 7.92▼ |
MA50 | 7.72▼ | 7.53▲ | 7.39▲ | 7.94▼ | 10.83▼ |
MA100 | 7.68▼ | 7.43▲ | 7.69▼ | 7.94▼ | 13.15▼ |
MA200 | 7.63▲ | 7.73▼ | 7.77▼ | 9.70▼ | 12.88▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.005▼ | -0.011▼ | 0.003▲ | -0.019▼ | 0.178▲ |
RSI | 40.779▼ | 51.884▲ | 56.291▲ | 48.768▼ | 40.999▼ |
STOCH | 41.270 | 35.595 | 66.670 | 40.662 | 28.001 |
WILL %R | -100.000▼ | -69.565 | -34.043 | -54.706 | -68.000 |
CCI | -153.317▼ | -48.562 | 46.858 | 1.196 | -87.040 |
MA | $CGEM Price Crossed Above MA(13) | Set Alert |
Thursday, August 07, 2025 04:13 AM
CLN-978 program now actively enrolling across Phase 1 studies in systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and Sjögren’s disease BCMA-directed bispecific T cell engager velinotamig ...
|
Thursday, July 31, 2025 08:40 PM
Cullinan Therapeutics Inc. (NASDAQ:CGEM) is one of the stocks under $10 to buy now. On July 22, Taiho Oncology Inc.
|
Tuesday, July 15, 2025 07:24 PM
Cullinan's innovative approach and Zipalertinib's potential approval in 2026 position it as a promising biotech investment. See here for more on CGEM stock.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 7.58 | 7.81 | 7.58 | 7.66 | 379,391 |
14/08/25 | 7.53 | 7.645 | 7.35 | 7.58 | 341,077 |
13/08/25 | 7.36 | 7.76 | 7.335 | 7.64 | 365,462 |
12/08/25 | 7.14 | 7.40 | 7.0901 | 7.27 | 302,567 |
11/08/25 | 7.27 | 7.33 | 6.91 | 7.09 | 411,050 |
08/08/25 | 7.04 | 7.57 | 6.89 | 7.295 | 544,965 |
07/08/25 | 7.61 | 7.80 | 6.95 | 7.03 | 486,564 |
06/08/25 | 8.01 | 8.01 | 7.75 | 7.88 | 225,546 |
05/08/25 | 7.94 | 8.13 | 7.86 | 8.08 | 229,744 |
04/08/25 | 7.67 | 8.00 | 7.52 | 7.94 | 272,441 |
|
|
||||
|
|
||||
|
|